Insulet (PODD) News Today $266.58 +4.59 (+1.75%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Segall Bryant & Hamill LLC Has $14.68 Million Stake in Insulet Co. (NASDAQ:PODD)Segall Bryant & Hamill LLC raised its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 33.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 63,052 shares of the medical instruments supplier's stock afterNovember 21 at 5:14 AM | marketbeat.comInsulet Corporation: Significant Opportunities, Significant Threats - I'm On The SidelinesNovember 20 at 9:02 PM | seekingalpha.comInsulet Corporation: Significant Opportunities, Significant Threats - I'm On The SidelinesNovember 20 at 7:11 PM | seekingalpha.com15,111 Shares in Insulet Co. (NASDAQ:PODD) Acquired by LMR Partners LLPLMR Partners LLP bought a new position in shares of Insulet Co. (NASDAQ:PODD - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 15,111 shares of the medical instruments supplier's stock, valued atNovember 19 at 5:36 AM | marketbeat.comInsulet's (NASDAQ:PODD) Solid Profits Have Weak FundamentalsNovember 17, 2024 | sg.finance.yahoo.comInsulet Co. (NASDAQ:PODD) Shares Purchased by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. grew its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 3.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 156,326 shares of the medical instruments supplier's stock afNovember 17, 2024 | marketbeat.comMizuho Securities USA LLC Has $75.84 Million Stake in Insulet Co. (NASDAQ:PODD)Mizuho Securities USA LLC lifted its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 5,928.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 325,821 shares of the medical instruments supplier's stock after purchasing an additional 320,4November 16, 2024 | marketbeat.comGSA Capital Partners LLP Acquires Shares of 4,370 Insulet Co. (NASDAQ:PODD)GSA Capital Partners LLP bought a new position in shares of Insulet Co. (NASDAQ:PODD - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 4,370 shares of the medical instruments supplier'sNovember 16, 2024 | marketbeat.comWilliam Blair Estimates Insulet's Q3 Earnings (NASDAQ:PODD)November 15, 2024 | americanbankingnews.comWhat is William Blair's Forecast for Insulet Q3 Earnings?Insulet Co. (NASDAQ:PODD - Free Report) - Research analysts at William Blair lifted their Q3 2025 EPS estimates for shares of Insulet in a report released on Monday, November 11th. William Blair analyst M. Andrew now anticipates that the medical instruments supplier will post earnings of $1.04 peNovember 14, 2024 | marketbeat.comPrincipal Financial Group Inc. Grows Holdings in Insulet Co. (NASDAQ:PODD)Principal Financial Group Inc. boosted its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 4.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,210 shares of the medical instruments suNovember 14, 2024 | marketbeat.comWilliam Blair Analysts Raise Earnings Estimates for InsuletNovember 14, 2024 | americanbankingnews.comInsider Sale: Director Luciana Borio Sells Shares of Insulet Corp (PODD)November 13, 2024 | gurufocus.comWhat is William Blair's Estimate for Insulet Q4 Earnings?Insulet Co. (NASDAQ:PODD - Free Report) - Stock analysts at William Blair upped their Q4 2024 earnings per share estimates for Insulet in a research note issued to investors on Monday, November 11th. William Blair analyst M. Andrew now forecasts that the medical instruments supplier will post earNovember 13, 2024 | marketbeat.comMorgan Stanley Increases Insulet (NASDAQ:PODD) Price Target to $317.00November 13, 2024 | americanbankingnews.comLos Angeles Capital Management LLC Has $3.24 Million Stock Position in Insulet Co. (NASDAQ:PODD)Los Angeles Capital Management LLC lowered its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 78.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,937 shares of the medical instruments supNovember 13, 2024 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Bought by Baillie Gifford & Co.Baillie Gifford & Co. boosted its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 20.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,275,701 shares of the medical instruments supplier's stock after acquirinNovember 12, 2024 | marketbeat.comQ4 Earnings Forecast for Insulet Issued By Leerink PartnrsNovember 12, 2024 | americanbankingnews.comInsulet price target raised to $317 from $234 at Morgan StanleyNovember 11, 2024 | markets.businessinsider.comInsulet price target raised to $234 from $220 at BarclaysNovember 11, 2024 | markets.businessinsider.comBarclays Raises Insulet (NASDAQ:PODD) Price Target to $234.00Barclays raised their price target on shares of Insulet from $220.00 to $234.00 and gave the stock an "equal weight" rating in a research note on Monday.November 11, 2024 | marketbeat.comBuy, Sell, Or Hold Insulet (PODD) Stock?November 11, 2024 | forbes.comInsulet (NASDAQ:PODD) Price Target Raised to $317.00Morgan Stanley increased their target price on Insulet from $234.00 to $317.00 and gave the stock an "overweight" rating in a research report on Monday.November 11, 2024 | marketbeat.comInsulet’s Strong Market Position and Growth Potential Justifies Buy RatingNovember 11, 2024 | markets.businessinsider.comInsulet’s Strong Performance and Growth Prospects Justify Buy RatingNovember 11, 2024 | markets.businessinsider.comLeerink Partnrs Has Bearish Estimate for Insulet Q4 EarningsInsulet Co. (NASDAQ:PODD - Free Report) - Stock analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for shares of Insulet in a research report issued to clients and investors on Thursday, November 7th. Leerink Partnrs analyst M. Kratky now anticipates that the medical iNovember 11, 2024 | marketbeat.comInsulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' ContinuesNovember 10, 2024 | msn.comOwnership Capital B.V. Sells 41,474 Shares of Insulet Co. (NASDAQ:PODD)Ownership Capital B.V. lessened its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 17.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 193,894 shares of the medical instruments supplier's stock after selling 41,474 sharesNovember 10, 2024 | marketbeat.comInsulet price target raised to $270 from $260 at BTIGNovember 10, 2024 | markets.businessinsider.comAEGON ASSET MANAGEMENT UK Plc Trims Position in Insulet Co. (NASDAQ:PODD)AEGON ASSET MANAGEMENT UK Plc reduced its position in Insulet Co. (NASDAQ:PODD - Free Report) by 18.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 135,549 shares of the medical instruments supplier's stock after selling 30,702 shares during the period. AEGONNovember 9, 2024 | marketbeat.comRobeco Institutional Asset Management B.V. Sells 2,624 Shares of Insulet Co. (NASDAQ:PODD)Robeco Institutional Asset Management B.V. reduced its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 9.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,049 shares of the medical instruments sNovember 9, 2024 | marketbeat.comInsulet (NASDAQ:PODD) Shares Up 10.7% After Analyst UpgradeInsulet (NASDAQ:PODD) Stock Price Up 10.7% on Analyst UpgradeNovember 8, 2024 | marketbeat.comInsulet (NASDAQ:PODD) Stock Price Expected to Rise, BTIG Research Analyst SaysBTIG Research upped their price objective on shares of Insulet from $260.00 to $270.00 and gave the company a "buy" rating in a report on Friday.November 8, 2024 | marketbeat.comInsulet Corp (PODD) Shares Up 10.69% on Nov 8November 8, 2024 | gurufocus.comInsulet’s Strong Market Performance and Growth Justify Buy RatingNovember 8, 2024 | markets.businessinsider.comInsulet Reports Strong Revenue Growth and Optimistic OutlookNovember 8, 2024 | markets.businessinsider.comInsulet Corp (PODD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ExpansionsNovember 8, 2024 | finance.yahoo.comABLE Financial Group LLC Invests $952,000 in Insulet Co. (NASDAQ:PODD)ABLE Financial Group LLC acquired a new position in Insulet Co. (NASDAQ:PODD - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,090 shares of the medical instruments suppliNovember 8, 2024 | marketbeat.comKornitzer Capital Management Inc. KS Sells 5,000 Shares of Insulet Co. (NASDAQ:PODD)Kornitzer Capital Management Inc. KS reduced its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 11.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 40,625 shares of the medical instruments supplier's stock aNovember 8, 2024 | marketbeat.comNational Pension Service Sells 2,430 Shares of Insulet Co. (NASDAQ:PODD)National Pension Service cut its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 1.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 128,664 shares of the medical instruments supplier's stock after selling 2,430 shares durinNovember 8, 2024 | marketbeat.comQ3 2024 Insulet Corp Earnings Call TranscriptNovember 8, 2024 | gurufocus.comInsulet Corporation (PODD) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comInsulet Corporation 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comInsulet raises annual revenue forecast on strong demand for insulin pumpsNovember 7, 2024 | reuters.comInsulet initiated with an Outperform at BernsteinNovember 6, 2024 | msn.comTandem, Insulet draw bullish views at Bernstein ahead of earningsNovember 6, 2024 | seekingalpha.comThis Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For WednesdayNovember 6, 2024 | msn.comInsulet (NASDAQ:PODD) Coverage Initiated at Sanford C. BernsteinSanford C. Bernstein assumed coverage on Insulet in a research report on Wednesday. They set an "outperform" rating and a $300.00 target price for the company.November 6, 2024 | marketbeat.comSymmetry Partners LLC Invests $924,000 in Insulet Co. (NASDAQ:PODD)Symmetry Partners LLC acquired a new stake in Insulet Co. (NASDAQ:PODD - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 3,968 shares of the medical instruments supplier's stock, valued at approximately $924,000. OtheNovember 2, 2024 | marketbeat.comInsulet rolls out iPhone app for Omnipod 5 insulin pump in USNovember 1, 2024 | msn.com Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO PODD Media Mentions By Week PODD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PODD News Sentiment▼0.990.45▲Average Medical News Sentiment PODD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PODD Articles This Week▼169▲PODD Articles Average Week Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NovoCure News Becton, Dickinson and Company News Edwards Lifesciences News ResMed News IDEXX Laboratories News DexCom News STERIS News Hologic News Baxter International News Globus Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PODD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insulet Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insulet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PODD Stock Alerts